Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Steffens

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|April 8, 2016
M1 signature mediators in atheroma-derived single cell secretome of symptomatic plaquesSabine Steffens
Cardiovascular Research|February 22, 2014
Fine tuning effector and regulatory T-cell dynamics: a novel tool for plaque regression?Sabine Steffens
Herz|December 16, 2004
Inflammation and atherosclerosisSabine Steffens, François Mach
British Journal of Pharmacology|May 23, 2012
Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversiesSabine Steffens, Pál Pacher
Thrombosis and Haemostasis|March 20, 2019
Immunotherapy for Atherosclerosis-Novel ConceptsSabine Steffens, Christian Weber
Nature Clinical Practice. Nephrology|August 26, 2006
Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Sabine Steffens, François Mach
Future Cardiology|October 7, 2009
Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosisSabine Steffens, François Mach
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 7, 2012
Emerging role of epigenetics and miRNA in diabetic cardiomyopathyMohamed Asrih, Sabine Steffens
Current Drug Targets|December 4, 2014
The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?Sabine Steffens, Pal Pacher
American Journal of Physiology. Cell Physiology|February 17, 2021
Nonclassical monocytes in cardiovascular physiology and diseaseSibgha Tahir, Sabine Steffens
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|April 8, 2016
M1 signature mediators in atheroma-derived single cell secretome of symptomatic plaquesSabine Steffens
Cardiovascular Research|February 22, 2014
Fine tuning effector and regulatory T-cell dynamics: a novel tool for plaque regression?Sabine Steffens
Herz|December 16, 2004
Inflammation and atherosclerosisSabine Steffens, François Mach
British Journal of Pharmacology|May 23, 2012
Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversiesSabine Steffens, Pál Pacher
Thrombosis and Haemostasis|March 20, 2019
Immunotherapy for Atherosclerosis-Novel ConceptsSabine Steffens, Christian Weber
Nature Clinical Practice. Nephrology|August 26, 2006
Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Sabine Steffens, François Mach
Future Cardiology|October 7, 2009
Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosisSabine Steffens, François Mach
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 7, 2012
Emerging role of epigenetics and miRNA in diabetic cardiomyopathyMohamed Asrih, Sabine Steffens
Current Drug Targets|December 4, 2014
The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?Sabine Steffens, Pal Pacher
American Journal of Physiology. Cell Physiology|February 17, 2021
Nonclassical monocytes in cardiovascular physiology and diseaseSibgha Tahir, Sabine Steffens
Pageof 13